Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study

NCT ID: NCT06004063

Last Updated: 2026-02-03

Basic Information

• Recruitment Status: ACTIVE_NOT_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 3 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-08-04
• Study Completion Date: 2029-12-31

Brief Summary

The goal of this research study is to learn if feeding someone after a stem cell transplant is safe and practical.

Detailed Description

Primary Objective:

a. To determine the feasibility, acceptability, and safety of NG tube feeding compared with patients not electing NG tube feeding.

Secondary Objectives:

1. Determine the differential effects of enteral feeding versus Parenteral feeding on nutrition, and quality of life.

2. Determine the differential effects of enteral feeding versus parenteral feeding on survival and, medical comorbidities

3. Determine the differential effects of enteral feeding versus parenteral feeding on Fitbit data study for patients co-enrolled in Pediatric Energy Balance Data Repository Protocol PA18-0130.

4. Identify differential effects on microbiome for patients co-enrolled on MDACC protocol 2014-0938 "Longitudinal Biospecimen Acquisition for All Tumor Types And At-Risk Tissue

5. Determine adverse effects of enteral feeding in this population

Conditions

Stem Cell

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: SINGLE

Study Groups

Standard care parenteral nutrition (PN)-Group 2

Participants will receive the standard of care. Participants will be monitored by a dietician to see if the participants are able to receive your daily caloric needs by mouth. Some participants may be able to receive oral dietary supplements, but if this is not possible or not enough, participants will begin receiving standard of care feeding by vein.

Group Type: ACTIVE_COMPARATOR

Standard care parenteral nutrition (PN)

Intervention Type: OTHER

Given by PO or Given by IV (vein)

Enteral nutrition (EN)-Group 1

Participants will receive enteral feeding (directly into the stomach) based on your ability to receive your daily caloric needs by mouth. Participants will be monitored by a dietician and may receive feeding by vein to achieve caloric goals.

Group Type: EXPERIMENTAL

Enteral nutrition (EN)

Intervention Type: DIETARY_SUPPLEMENT

Given by Nasogastric Tube

Standard care parenteral nutrition (PN)

Intervention Type: OTHER

Given by PO or Given by IV (vein)

Interventions

Enteral nutrition (EN)

Given by Nasogastric Tube

Intervention Type: DIETARY_SUPPLEMENT

Standard care parenteral nutrition (PN)

Given by PO or Given by IV (vein)

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Have plans to be admitted or be admitted to an inpatient pediatric or adult ward for the purpose of HSCT.

2. Be greater than 2 years of age and less than 25 years of age at time of study enrollment.

3. Participants > 18 or guardians for participants < 18 are willing and able to give written informed consent and to comply with all of the study activities. Assent is required for children > 7 years old.

a) Participants must be English, Italian, Chinese/Mandarin, or Spanish speaking

4. Participants will be encouraged to co-enroll on two additional related energy -balance protocols (highly encouraged but not required)

1. MDACC protocol PA18-0130. This protocol will enable us to track physical activity through their receipt of a Fitbit (Pediatric Energy Balance Data Repository Protocol.) , and

2. MDACC protocol LAB99-062 "A Study to Collect Peripheral Blood, Tissue, and Bone Marrow samples from Donors and Recipients of blood and marrow transplants for Laboratory Research" which will allow collection of stool for exploration of the effects of feeding on microbiome data specifically.

5. Participants will be asked to consider co-enrollment on Stem Cell Registry study (not required):

1. PA19-0756: This is a prospective multi-center study to understand the contribution of vascular endothelial dysfunction towards morbidity and mortality among children and adolescents/young adults (AYA) undergoing HCT/CT.

Exclusion Criteria

1. Patients in whom EN is contraindicated (e.g intestinal ischemia, complete bowel obstruction, or other anatomical obstructive process), or all available routes of EN are contraindicated. Surgical GT placements for the sole purpose of study participation will not be entertained. See Table 1

2. Females who are pregnant. We follow FACT guidelines. Per Foundation for the Accreditation of Cellular Therapy (FACT), female patients must have a negative pregnancy test 7 days prior to bone marrow transplant.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

M.D. Anderson Cancer Center

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Shehla Razvi, MD

Role: PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Locations

M D Anderson Cancer Center

Houston, Texas, United States

Countries

United States

Related Links

http://www.mdanderson.org

M D Anderson Cancer Center

Other Identifiers

NCI-2023-06448

Identifier Type: OTHER

Identifier Source: secondary_id

2021-0116

Identifier Type: -

Identifier Source: org_study_id